Search research articles
Contact Us
Filters
Showing results (631-640 of 771) with videos related to
Page
of 78
Sort By:
Journal of Community Health
|
June 1, 2025
Community-level Social Vulnerability and Cervical Cancer Mortality Among Young and Old Adults in the State of Alabama
Pranali G Patel, Sabrina Chowdhury, Howard W Wiener, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 27, 2016
Neurokinin B Receptor Antagonism in Women With Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled Trial
Jyothis T George, Rahul Kakkar, Jayne Marshall, et al.
Advanced Healthcare Materials
|
April 14, 2015
Ovarian cancer immunotherapy using PD-L1 siRNA targeted delivery from folic acid-functionalized polyethylenimine: strategies to enhance T cell killing
Pei Yun Teo, Chuan Yang, Lynsey M Whilding, et al.
Molecular Cell
|
December 5, 2023
ER chaperones use a protein folding and quality control glyco-code
Kevin P Guay, Haiping Ke, Nathan P Canniff, et al.
Archives of Physical Medicine and Rehabilitation
|
October 6, 2009
Observation of amounts of movement practice provided during stroke rehabilitation
Catherine E Lang, Jillian R Macdonald, Darcy S Reisman, et al.
Clinical Kidney Journal
|
December 8, 2018
The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study
William G Herrington, David Preiss, Richard Haynes, et al.
Circulation
|
December 28, 2018
Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial
David Fitchett, Silvio E Inzucchi, Christopher P Cannon, et al.
Psychiatric Research and Clinical Practice
|
November 8, 2021
Common Factors Underlying Diverse Responses in Alcohol Use Disorder
Esha Chebolu, Melanie L Schwandt, Vijay A Ramchandani, et al.
Journal of the American Heart Association
|
March 23, 2021
Cardio/Kidney Composite End Points: A Post Hoc Analysis of the EMPA-REG OUTCOME Trial
João Pedro Ferreira, Bettina Johanna Kraus, Isabella Zwiener, et al.
Diabetes, Obesity & Metabolism
|
August 31, 2021
Effects of empagliflozin on insulin initiation or intensification in patients with type 2 diabetes and cardiovascular disease: Findings from the EMPA-REG OUTCOME trial
Muthiah Vaduganathan, Silvio E Inzucchi, Naveed Sattar, et al.
Page
of 78
Search research articles
Search
Showing results (631-640 of 771) with videos related to
Sort By:
Page
of 78
Journal of Community Health
|
June 1, 2025
Community-level Social Vulnerability and Cervical Cancer Mortality Among Young and Old Adults in the State of Alabama
Pranali G Patel, Sabrina Chowdhury, Howard W Wiener, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 27, 2016
Neurokinin B Receptor Antagonism in Women With Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled Trial
Jyothis T George, Rahul Kakkar, Jayne Marshall, et al.
Advanced Healthcare Materials
|
April 14, 2015
Ovarian cancer immunotherapy using PD-L1 siRNA targeted delivery from folic acid-functionalized polyethylenimine: strategies to enhance T cell killing
Pei Yun Teo, Chuan Yang, Lynsey M Whilding, et al.
Molecular Cell
|
December 5, 2023
ER chaperones use a protein folding and quality control glyco-code
Kevin P Guay, Haiping Ke, Nathan P Canniff, et al.
Archives of Physical Medicine and Rehabilitation
|
October 6, 2009
Observation of amounts of movement practice provided during stroke rehabilitation
Catherine E Lang, Jillian R Macdonald, Darcy S Reisman, et al.
Clinical Kidney Journal
|
December 8, 2018
The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study
William G Herrington, David Preiss, Richard Haynes, et al.
Circulation
|
December 28, 2018
Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA-REG OUTCOME Trial
David Fitchett, Silvio E Inzucchi, Christopher P Cannon, et al.
Psychiatric Research and Clinical Practice
|
November 8, 2021
Common Factors Underlying Diverse Responses in Alcohol Use Disorder
Esha Chebolu, Melanie L Schwandt, Vijay A Ramchandani, et al.
Journal of the American Heart Association
|
March 23, 2021
Cardio/Kidney Composite End Points: A Post Hoc Analysis of the EMPA-REG OUTCOME Trial
João Pedro Ferreira, Bettina Johanna Kraus, Isabella Zwiener, et al.
Diabetes, Obesity & Metabolism
|
August 31, 2021
Effects of empagliflozin on insulin initiation or intensification in patients with type 2 diabetes and cardiovascular disease: Findings from the EMPA-REG OUTCOME trial
Muthiah Vaduganathan, Silvio E Inzucchi, Naveed Sattar, et al.
Page
of 78